Oxford Cognitive Screen: Transforming stroke recovery through inclusive cognitive testing

Each year, millions of people around the world experience a stroke – a life-altering event that can affect memory, speech, attention and more. Recovery depends not only on urgent medical care but also on accurately understanding the subsequent effects on the brain.

Traditional cognitive ability tests often fall short – particularly for stroke survivors with language difficulties, visual field loss, or mobility impairments. 

Developed at the University of Oxford under the leadership of neuropsychologist Professor Nele Demeyere, the Oxford Cognitive Screen (OCS) was designed to change that, effecting significant change in cognitive testing and enhancing patient outcomes. The OCS is a stroke-specific tool that provides a clear visual summary of a patient’s cognitive profile across five key areas: language, memory, movement, numeracy, and attention. It is designed to be quick, inclusive, and easily administered at the bedside – even in the early stages after a stroke. 

Crucially, the OCS accounts for common post-stroke complications that can confound traditional tests. This makes it a powerful tool for clinicians to identify cognitive strengths and weaknesses, enabling more personalised rehabilitation plans and improving long-term outcomes for patients. Since its release in 2015, the OCS has been adopted as a first-line screening tool in stroke units across the UK and internationally, with over 2,200 licence agreements and 26 translations in use worldwide – all overseen by the expertise of OUI’s Clinical Outcomes team. 

To support further research and validation of a digital version of OCS, Oxford University Innovation’s Consulting Services team helped arrange a service and consultancy agreement with Brain Stimulation. This enabled Professor Demeyere and the Nuffield Department of Clinical Neurosciences to advise on a major psychometric evaluation study, including study design, data analysis, ethical approvals, and the setup of a UK arm of the research. 

The success of OCS has led to a suite of follow-up tools, including the tablet-based OCS and OCS-Plus for detecting subtler impairments, and the Tele-OCS, which enables remote cognitive assessments. The team has also developed OxMET, a short digital task assessing executive function through a simulated shopping scenario, helping to evaluate how cognitive changes affect real-world tasks. 

Together, these tools are reshaping stroke care, making cognitive assessment more accessible, more accurate, and more meaningful for patients navigating recovery. 

Impact

  • Research shows early cognitive screening can provide valuable prognostic information for longer-term cognitive outcomes 
  • Translated into 26 languages
  • OCS takes only 15 to 20 minutes to complete 
  • Free for publicly funded clinical and research use (charges apply for use by commercial organisations)  

It is an honour to be able to spread the use of the OCS, which provides a dedicated stroke-specific and domain-specific cognitive screen. 

Dr Helena Fordell - Founder and Chief Medical Officer, Brain Stimulation  

OUI activities

  • Communication & marketing
  • IP identification and protection
  • Licensing & contracts

Case study categories

  • Health Tech

SDGs addressed

  • 03 Good Health and Well-Being